Online citations, reference lists, and bibliographies.
← Back to Search

What Parathyroid Hormone Levels Should We Aim For In Children With Stage 5 Chronic Kidney Disease; What Is The Evidence?

L. Rees
Published 2007 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The bone disease that occurs as a result of chronic kidney disease (CKD) is not only debilitating but also linked to poor growth and cardiovascular disease. It is suspected that abnormal bone turnover is the main culprit for these poor outcomes. Plasma parathyroid hormone (PTH) levels are used as a surrogate marker of bone turnover, and there is a small number of studies in children that have attempted to identify the range of PTH levels that correlates with normal bone histology. It is clear that high PTH levels are associated with high bone turnover, although the range is wide. However, the ability of PTH levels to distinguish between low and normal bone turnover is less clear. This is an important issue, because current guidelines for calcium and phosphate management are based upon there being an “optimum” range for PTH. This editorial takes a critical look at the evidence upon which these recommendations are based.
This paper references
10.1001/ARCHPEDI.1976.02120100047007
Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease.
A. Pennisi (1976)
10.1038/KI.1982.107
Quantitative bone histology in children with chronic renal failure.
E. Hodson (1982)
Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
A. R. Watson (1988)
Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
R. Mathias (1993)
10.1038/KI.1994.380
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
W. G. Goodman (1994)
10.1038/KI.1994.31
Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
I. Salusky (1994)
10.1046/J.1523-1755.1998.00724.X
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.
B. Kuizon (1998)
10.1046/J.1523-1755.1999.00575.X
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.
S. Rostand (1999)
10.1111/j.1651-2227.2000.tb00361.x
Bone biopsy results and serum bone turnover parameters in uremic children
H. Ziółkowska (2000)
10.1046/j.1442-200x.2000.01171.x
Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis
F. Yalçınkaya (2000)
10.1046/J.1523-1755.2000.00013.X
Outcome and growth of infants with severe chronic renal failure.
J. Kari (2000)
10.1093/ndt/16.3.689
Coronary artery calcifications in children and young adults treated with renal replacement therapy.
F. Eifinger (2000)
10.1056/NEJM200005183422003
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.
W. G. Goodman (2000)
Outcome and growth of infants with chronic renal failure
JA Kari (2000)
10.1093/NDT/16.10.2041
Arterial changes in paediatric haemodialysis patients undergoing renal transplantation.
A. Nayır (2001)
10.1097/01.ASN.0000037677.16961.DF
Increased arterial stiffness in young adults with end-stage renal disease since childhood.
J. Groothoff (2002)
10.1161/01.CIR.0000020222.63035.C0
Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure
J. Oh (2002)
10.1007/s00467-003-1267-1
Parathyroid hormone and its fragments in children with chronic renal failure
Simon C Waller (2003)
10.1097/01.ASN.0000129337.50739.48
Arterial calcifications and bone histomorphometry in end-stage renal disease.
G. London (2004)
10.1007/BF00867483
Soft tissue calcification in pediatric patients with end-stage renal disease
D. Milliner (2004)
10.1097/01.TP.0000128616.02821.8B
Long-Term Follow-Up of Renal Transplantation in Children: A Dutch Cohort Study
J. Groothoff (2004)
10.1681/ASN.2004110932
Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation.
M. Litwin (2005)
10.1007/s00467-005-2082-7
Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines
G. Klaus (2005)
10.1681/ASN.2005030291
Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.
M. Mitsnefes (2005)
Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calciumphosphorus metabolism
MM Mitsnefes (2005)
10.1016/J.GHIR.2006.03.003
Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations.
C. Langman (2006)
10.1038/SJ.KI.5000414
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
S. Moe (2006)
10.1007/s00467-006-0159-6
Coronary artery calcifications in children with end-stage renal disease
M. Çivilibal (2006)
10.1093/NDT/GFL098
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.
Sonia Briese (2006)
10.1016/J.TRANSPROCEED.2006.10.198
Early coronary calcification in children and young adults with end-stage renal disease.
A. Lumpaopong (2007)
10.1007/s00467-006-0348-3
Growth and PTH in prepubertal children on long-term dialysis
J. Cansick (2007)
10.1681/ASN.2006121397
Mineral metabolism and vascular damage in children on dialysis.
R. Shroff (2007)
Growth in prepubertal children on long-term dialysis
J Cansick (2007)
Renal osteodystrophy In: Paediatric nephrology
L Rees (2007)
The impact of vitamin D levels on vascular structure and calcification in children on dialysis
R Shroff (2007)
Renal osteodystrophy In: Paediatric nephrology. Chapter 24
L Rees (2007)
10.1681/ASN.2007090993
A bimodal association of vitamin D levels and vascular disease in children on dialysis.
R. Shroff (2008)
Pediatr Nephrol
(2008)



This paper is referenced by
10.1093/ndt/gfaa199
Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.
A. Lalayiannis (2020)
10.1007/s00467-019-04421-5
CKD-MBD post kidney transplantation
D. Haffner (2019)
10.1007/s00467-019-04271-1
Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available?
A. Lalayiannis (2019)
10.1007/s00467-019-04399-0
Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels
D. Haffner (2019)
10.1007/s00467-018-4055-7
Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease
Aura J Arenas Morales (2018)
10.1007/s00467-017-3675-7
Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients
M. Freundlich (2017)
10.1007/978-3-662-43596-0_63
Hemodialysis in children
L Rees (2015)
Chronic kidney disease and secondary hyperparathyroidism in children
A. Gheissari (2014)
10.1007/s00467-012-2270-1
Searching the optimal PTH target range in children undergoing peritoneal dialysis: New insights from international cohort studies
D. Haffner (2012)
10.1007/978-1-4614-0721-8_22
Meeting Nutritional Goals for Children Receiving Maintenance Dialysis
B. Warady (2012)
10.1093/ndt/gfs299
The consequences of chronic kidney disease on bone metabolism and growth in children.
J. Bacchetta (2012)
10.1007/978-3-642-02202-9_313
Chronic Kidney Disease (CKD)
L. Rees (2012)
Az urémia és a vesetranszplantáció vaszkuláris hatásai gyermekkorban Doktori értekezés
Tulassay Tivadar (2012)
10.1007/s00467-012-2173-1
Intima media thickness in children undergoing dialysis
L. Chavarria (2012)
10.2215/CJN.04760511
Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
R. Shroff (2012)
10.1007/s12018-011-9112-8
Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder
Juhi Kumar (2011)
10.1038/nrneph.2011.116
Cardiovascular complications in children with chronic kidney disease
R. Shroff (2011)
10.1002/EBCH.703
Commentary on ‘Interventions for bone disease in children with chronic kidney disease’
R. Shroff (2011)
10.1007/s00467-010-1691-y
Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?
R. Shroff (2011)
10.1097/MNH.0b013e3283455e8c
Dysregulated mineral metabolism in children with chronic kidney disease
R. Shroff (2011)
10.1007/s00467-010-1614-y
Parathyroid hormone and growth in chronic kidney disease
S. Waller (2010)
10.1016/B978-1-4377-0987-2.00017-0
Chapter 17 – The Pediatric Patient with Chronic Kidney Disease
Bradley A. Warady (2010)
10.1007/s00467-010-1574-2
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window
U. Querfeld (2010)
10.1007/s00467-010-1499-9
The virtues of vitamin D—but how much is too much?
R. Shroff (2010)
Uraemic vascular damage and calcification in children withchronic kidney disease
R. Shroff (2009)
10.1007/s00467-008-1084-7
Growth hormone treatment started in the first year of life in infants with chronic renal failure
F. Mencarelli (2009)
10.1007/s00467-008-0838-6
Bone histomorphometry in children prior to commencing renal replacement therapy
S. Waller (2008)
Semantic Scholar Logo Some data provided by SemanticScholar